Cited by — Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab.
No admitted local citation edges point to this work yet.
